Acquisition / mergerFiled on BSE ·
KIMS announces acquisition of up to 51% stake in Insignia Healthcare Pvt Ltd
Krishna Institu. · Healthcare Services
What the filing says
- KIMS to acquire up to 51% equity stake in Insignia Healthcare, a healthcare O&M company
- Acquisition price set at ₹30.35 per share based on BDO valuation dated 05 Oct 2026; payment in cash
- Insignia operates a 150-bed hospital in Guntur, Andhra Pradesh, with FY25 turnover ₹104.5 crore and incorporated on 02-07-2018
Original filing
Announcement under Regulation 30 (LODR)-Acquisition
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Krishna Institu.
- Acquisition / mergerKIMS to acquire 51% stake in Sarvottam Health Care for up to ₹80 crore
Other acquisition / merger filings this fortnight
- Acquisition / mergerSudarshan Pharma Industries LtdSudarshan Pharma terminates acquisition of 9.50% equity in Med Therapy Biotechnology Inc.
- Acquisition / mergerInox Green Energy Services LtdInox Green completes ₹550 crore payment for Wind World India’s 4.5 GW Wind O&M transfer
- Acquisition / mergerInox Green Energy Services LtdInox Green Energy Services acquires Wind World O&M business via Vibhav Energy
- Acquisition / mergerMaharashtra Seamless LtdMaharashtra Seamless Limited approves demerger scheme for two units into subsidiaries
- Acquisition / mergerSky Gold & Diam.Sky Gold & Diamonds acquires Purvi Gems for ₹9 crore to boost growth and diversification
- Acquisition / mergerSky Gold & Diam.Sky Gold and Diamonds completes acquisition of Purvi Gems & Jewellery Pvt Ltd
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.